Related Experiment Video
Updated: May 29, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
A double blind comparative study of usefulness of clonidine and symptomatic therapy in opiate detoxication
D C Satija1, G D Natani, D R Purohit
1Professor & Head, Department of Psychiatry, Psychiatric Centre, Dr. S.N. Medical College, Jodhpur.
Abstract:
Several studies in West have indicated that clonidine hydrochloride, an adrenergic blocking agent is both safe and effective for detoxifying narcotic addicts. One hundred and two patients of opium addition admitted in Psychiatry Center Jodhpur were subjects for present study. The patients were divided into group A, B and C having thirty four in each group. These groups were identical with regards to sociodemographic variables, mean dose of opium and duration of intake. Group A was given clonidine in small doses, Group B symptomatic therapy and group C was given clonidine in high doses. Study was double blind. Record of blood pressure, pulse rate, other vital sign and withdrawal symptom (on Physician's Rating Scale) was kept twice daily, Treatment was continued for two weeks. Clonidine in high doses proved to be more effective than other therapies.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Toxidromes: Clinical Features
Analgesia and Pain Management
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Dependence
CNS Depressants: Alcohol and Nicotine